title: Stevens-Johnson Syndrome induced by masitinib.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Chaigne
authors.forename: Louise
authors.initials: L
authors.lastname: Lagier
authors.forename: Alexander
authors.initials: A
authors.lastname: Aubourg
authors.forename: Anne
authors.initials: A
authors.lastname: de Muret
authors.forename: Annie-Pierre
authors.initials: AP
authors.lastname: Jonville-Bera
authors.forename: Laurent
authors.initials: L
authors.lastname: Machet
authors.forename: Mahtab
authors.initials: M
authors.lastname: Samimi
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D001549:Benzamides; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011725:Pyridines; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D001549:Benzamides; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D013844:Thiazoles; C526575:masitinib